CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
WIM2022: Transcripts of Fireside Chat: China Globalization [2/2]
Yesterday 03:00 PM
WIM2022: Transcripts of Fireside Chat: China Globalization [1/2]
Yesterday 02:56 PM